T

T. Rowe Price

8291 employees

T. Rowe Price is an investment management firm that focuses on funding technology startups.

Investor insights

Sectors invested in

Biotechnology90
Health Care74
Medical51
Software43
Therapeutics32
Artificial Intelligence28
E-Commerce25
Pharmaceutical25
Life Science23
Information Technology22
Machine Learning21
Health Diagnostics19
Enterprise Software18
SaaS18
Medical Device17
Biopharma16
FinTech16
Transportation15
Genetics15
Technology15

Funding rounds participated in

$125M sweet spot round size

Most of their 293 investments are in rounds between $75M and $250M

Investor type

Private Equity Firm

Basic info

Industry

financial services

Sectors

Retirement Planning
Financial Services
Mutual Funds
Financial Exchanges
Finance
Retirement Plans
Separate Accounts
Subadvisory Services
College Planning
Asset Management
IRAs
Business Development

Date founded

1937

Investments made

D

Databricks raised $504M on September 14, 2023

Investors: GIC, Eastlink Capital, Octahedron Capital and T. Rowe Price

R

Redwood Materials raised $1B on August 29, 2023

Investors: OMERS Ventures, Goldman Sachs Asset Management, Capricorn Investment Group and T. Rowe Price

R

Rapport Therapeutics raised $150M on August 23, 2023

Investors: Logos Global Management, LP, Surveyor Capital, Goldman Sachs Asset Management, Sofinnova Ventures, Russia technology fund, Third Rock Ventures, Perceptive Advisors and T. Rowe Price

G

Genesis Therapeutics raised $200M on August 21, 2023

Investors: Radical Ventures, Menlo Ventures, Andreessen Horowitz, nVentures PTE LTD and T. Rowe Price

K

KoBold Metals raised $195M on June 20, 2023

Investors: Mitsubishi Corporation, Earthshot Ventures, Equinor Ventures, Breakthrough Energy Ventures, July Fund, Andreessen Horowitz, Standard Investments and T. Rowe Price

R

Ring Therapeutics raised $87M on March 9, 2023

Investors: CJ Investment Inc., UPMC Enterprises, The Invus Group, Partners Investment, Flagship Ventures and T. Rowe Price

V

VERAI DISCOVERIES raised $12M on March 2, 2023

Investors: Chrysalix EVC, Orion Resource Partners (USA) LP, Blumberg Capital and T. Rowe Price

C

CARGO Therapeutics raised $200M on March 1, 2023

Investors: Nextech Invest, Perceptive Advisors, Red Tree Venture Capital, RTW Investments, LP, Samsara BioCapital, Wellington Management, Third Rock Ventures and T. Rowe Price

C

Chroma Medicine raised $135M on March 1, 2023

Investors: Osage University Partners (OUP), Sixth Street, Omega Funds, Sofinnova Partners, Wellington Management, GV, Newpath Partners and T. Rowe Price

U

Undisclosed raised $150M on February 21, 2023

Investors: T. Rowe Price

FAQ